Products

What will AGI do for Amlexanox?

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H14N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BRL1C2459K, chemically known as 5h-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid, 2-amino-7-(1-methylethyl)-5-oxo- but generally known as amlexanox, which bears US NIH Compound Identifier 2161. European Medicines Agency schedules Amlexanox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05465MIG. The term AMLEXANOX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules amlexanox in its Anatomical Therapeutic Chemical (ATC) Classification. AMLEXANOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amlexanox under HS 29349990 and SITC 51579. As of Q4 2014, AMLEXANOX remains the US FDA Preferred Term for this commodity. Amlexanox bears US NLM identifiers UMLS ID C0103049 and NCI Concept Code C47395. SMILES: O1C2C(CC(C(C)C)CC2)C(=O)C2C1NC(N)C(C2)C(=O)O.